For the production of domestically produced serum-free media for hybridoma and monoclonal antibodies, etc.!
"Extreme East E-RDF medium" allows for high-density and long-term large-scale culture! Suitable for the culture of human and mouse hybridomas/myelomas. Ideal for the production of useful substances.
"Kyokuto E-RDF Medium" is a serum-free medium suitable for the culture of hybridomas. This product is an improved version of RDF (RPMI1640:DMEM:Ham F12 = 2:1:1), with a more enriched composition. It is suitable for the culture of human and mouse hybridomas and myelomas (such as NS-1, MPC-11, MCB-1). It is ideal for the production of useful substances such as monoclonal antibodies through high-density and large-scale culture, and we also offer "Kyokuto Cell Culture Medium Additive RD-1" as an additive. By using a medium supplemented with "Kyokuto Cell Culture Medium Additive RD-1," good growth of hybridomas and long-term large-scale culture at high density can be achieved. "Kyokuto Cell Culture Medium Additive RD-1" contains insulin, transferrin, and ethanolamine. *Toxic substance 【Specifications】 ■ Code: 551-26500-2 ■ Storage method: Dark, moisture-proof 2–10℃ ■ Expiration date: 2 years ■ Packaging: 177g for 10L *Custom media can also be prepared by removing or adding specified substances according to your requirements.
Inquire About This Product
basic information
For more details, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■ Culture of hybridomas ■ Production of useful substances such as monoclonal antibodies through high-density, large-scale culture *For more details, please feel free to contact us.
catalog（4）
Download All Catalogs
Company information
Since its founding, Kyokuto Pharmaceutical Industrial has supported the medical field in protecting human "health" through the manufacture and sale of bacterial culture media, media and reagents for bacterial testing, and clinical testing reagents and equipment. Looking to the future, we are now adding the perspective of "preventive medicine testing" to our traditional focus on "diagnostic and therapeutic testing." Based on the technologies and know-how accumulated in clinical testing, we are also venturing into the fields of cell culture-related products that serve as raw materials for advanced medicine and pharmaceuticals, as well as food and environmental testing, embarking on new challenges.